181 related articles for article (PubMed ID: 3101590)
1. In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
Liebowitz LD; Saunders J; Fehler G; Ballard RC; Koornhof HJ
Antimicrob Agents Chemother; 1986 Dec; 30(6):948-50. PubMed ID: 3101590
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
Tjiam KH; Wagenvoort JH; van Klingeren B; Piot P; Stolz E; Michel MF
Eur J Clin Microbiol; 1986 Oct; 5(5):498-501. PubMed ID: 3096726
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens.
Bowie WR; Shaw CE; Chan DG; Boyd J; Black WA
Antimicrob Agents Chemother; 1986 Oct; 30(4):590-3. PubMed ID: 3098163
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of lomefloxacin against Chlamydia trachomatis, Neisseria gonorrhoeae, Haemophilus ducreyi, Mycoplasma hominis, and Ureaplasma urealyticum.
Hoban D; DeGagne P; Witwicki E
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):83S-86S. PubMed ID: 2507222
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogens.
Lefèvre JC; Bauriaud R; Gaubert E; Escaffre MC; Lareng MB
Chemotherapy; 1992; 38(5):303-7. PubMed ID: 1337506
[TBL] [Abstract][Full Text] [Related]
6. Activity of ciprofloxacin against genital tract pathogens.
Hart CA; How SJ; Hobson D
Br J Vener Dis; 1984 Oct; 60(5):316-8. PubMed ID: 6435814
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis.
Slaney L; Chubb H; Ronald A; Brunham R
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():1-5. PubMed ID: 2154426
[TBL] [Abstract][Full Text] [Related]
8. The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
Ridgway GL; Mumtaz G; Gabriel FG; Oriel JD
Eur J Clin Microbiol; 1984 Aug; 3(4):344-6. PubMed ID: 6237903
[TBL] [Abstract][Full Text] [Related]
9. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
Soussy CJ; Deforges L; Le Van Thoi J; Duval J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811
[TBL] [Abstract][Full Text] [Related]
10. Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
Verbist L
J Antimicrob Chemother; 1987 Sep; 20(3):363-72. PubMed ID: 3119552
[TBL] [Abstract][Full Text] [Related]
11. Activities of new quinoline derivatives against genital pathogens.
Aznar J; Caballero MC; Lozano MC; de Miguel C; Palomares JC; Perea EJ
Antimicrob Agents Chemother; 1985 Jan; 27(1):76-8. PubMed ID: 3920959
[TBL] [Abstract][Full Text] [Related]
12. Comparative in-vitro activity of sparfloxacin against genital pathogens.
Perea EJ; Aznar J; Garcia-Iglesias MC; Pascual A
J Antimicrob Chemother; 1996 May; 37 Suppl A():19-25. PubMed ID: 8737122
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of A-56619 (difloxacin) and A-56620, two aryl fluoroquinolones.
Digranes A; Dibb WL
Chemotherapy; 1988; 34(4):298-307. PubMed ID: 3208547
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of amifloxacin (WIN 49,375) compared with those of ciprofloxacin and ofloxacin.
Digranes A
Acta Pathol Microbiol Immunol Scand B; 1987 Feb; 95(1):29-32. PubMed ID: 3105246
[TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
Renaudin H; Quentin C; de Barbeyrac B; Bebear C
Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis.
Talbot H; Romanowski B
Antimicrob Agents Chemother; 1989 Dec; 33(12):2049-51. PubMed ID: 2533473
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis.
Nagayama A; Nakao T; Taen H
Antimicrob Agents Chemother; 1988 Nov; 32(11):1735-7. PubMed ID: 3150916
[TBL] [Abstract][Full Text] [Related]
19. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
King A; Phillips I
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620 compared to that of other antimicrobial agents.
Hirschhorn L; Neu HC
Chemotherapy; 1987; 33(1):28-39. PubMed ID: 3549179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
